TY - JOUR
T1 - C-reactive protein and pentraxin-3 binding of factor H-like protein 1 differs from complement factor H
T2 - implications for retinal inflammation
AU - Swinkels, Maurice
AU - Zhang, Justine H
AU - Tilakaratna, Viranga
AU - Black, Graeme
AU - Perveen, Rahat
AU - McHarg, Selina
AU - Inforzato, Antonio
AU - Day, Anthony J
AU - Clark, Simon J
PY - 2018/1/26
Y1 - 2018/1/26
N2 - Retinal inflammation plays a key role in the progression of age-related macular degeneration (AMD), a condition that leads to loss of central vision. The deposition of the acute phase pentraxin C-reactive protein (CRP) in the macula activates the complement system, thereby contributing to dysregulated inflammation. The complement protein factor H (FH) can bind CRP and down-regulate an inflammatory response. However, it is not known whether a truncated form of FH, called factor H-like protein 1 (FHL-1), which plays a significant regulatory role in the eye, also interacts with CRP. Here, we compare the binding properties of FHL-1 and FH to both CRP and the related protein pentraxin-3 (PTX3). We find that, unlike FH, FHL-1 can bind pro-inflammatory monomeric CRP (mCRP) as well as the circulating pentameric form. Furthermore, the four-amino acid C-terminal tail of FHL-1 (not present in FH) plays a role in mediating its binding to mCRP. PTX3 was found to be present in the macula of donor eyes and the AMD-associated Y402H polymorphism altered the binding of FHL-1 to PTX3. Our findings reveal that the binding characteristics of FHL-1 differ from those of FH, likely underpinning independent immune regulatory functions in the context of the human retina.
AB - Retinal inflammation plays a key role in the progression of age-related macular degeneration (AMD), a condition that leads to loss of central vision. The deposition of the acute phase pentraxin C-reactive protein (CRP) in the macula activates the complement system, thereby contributing to dysregulated inflammation. The complement protein factor H (FH) can bind CRP and down-regulate an inflammatory response. However, it is not known whether a truncated form of FH, called factor H-like protein 1 (FHL-1), which plays a significant regulatory role in the eye, also interacts with CRP. Here, we compare the binding properties of FHL-1 and FH to both CRP and the related protein pentraxin-3 (PTX3). We find that, unlike FH, FHL-1 can bind pro-inflammatory monomeric CRP (mCRP) as well as the circulating pentameric form. Furthermore, the four-amino acid C-terminal tail of FHL-1 (not present in FH) plays a role in mediating its binding to mCRP. PTX3 was found to be present in the macula of donor eyes and the AMD-associated Y402H polymorphism altered the binding of FHL-1 to PTX3. Our findings reveal that the binding characteristics of FHL-1 differ from those of FH, likely underpinning independent immune regulatory functions in the context of the human retina.
KW - C-Reactive Protein/metabolism
KW - Complement C3b Inactivator Proteins/metabolism
KW - Complement Factor H/metabolism
KW - Humans
KW - Protein Binding
KW - Retinitis/pathology
KW - Serum Amyloid P-Component/metabolism
U2 - 10.1038/s41598-017-18395-7
DO - 10.1038/s41598-017-18395-7
M3 - Article
C2 - 29374201
SN - 2045-2322
VL - 8
SP - 1643
JO - Scientific Reports
JF - Scientific Reports
IS - 1
ER -